Skip to content

Author

Elisabeth Framke

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Dipeptidyl peptidase-4 inhibitors and risk of multiple sclerosis: A Danish nationwide matched case-control study.

BACKGROUND Treatment with dipeptidyl peptidase-4 inhibitors (DPP-4i) is a strong risk factor for developing bullous pemphigoid, a dermatological disorder that is itself strongly associated with multiple sclerosis (MS). We therefore hypothesized that DPP-4i would also increase the risk of MS. OBJECTIVE To investigate...

Philip Ahle Erichsen, I. M. Heerfordt, Elisabeth Framke et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.